TY - GEN AU - Brüssow,Harald TI - Hurdles for Phage Therapy (PT) to Become a Reality SN - books978-3-03921-392-4 PY - 2019/// PB - MDPI - Multidisciplinary Digital Publishing Institute KW - alginate KW - abortive infection KW - n/a KW - bacterial resistance KW - bacteriophages KW - ATMP KW - MALDI-MS KW - adaptation KW - Bacteriophage KW - horizontal gene transfer KW - adaptive immunity KW - co-evolution KW - Listeria ivanovii KW - personalised medicines KW - pH stability KW - phage-human host interaction KW - vB_SauM-fRuSau02 KW - antimicrobial resistance KW - phagodisinfection KW - biofilm KW - capsule depolymerase KW - animal model KW - phage cocktails KW - Enterococcus KW - cases report KW - zoonosis KW - resistance KW - magistral formula KW - experimental therapy KW - Belgium KW - phage therapy KW - E. faecalis KW - nontraditional antibacterial KW - industrial phage application KW - Democratic Republic of the Congo KW - OrthoMCL KW - Germany KW - high-throughput sequencing KW - antimicrobial KW - infection KW - antibiotic therapy KW - Kayvirus KW - phages KW - Twortlikevirus KW - bacterial disease KW - human host KW - Pseudomonas aeruginosa KW - phage KW - multidrug-resistant bacteria KW - bacterial infection KW - Salmonella Typhi KW - rhamnopolysaccharide KW - compassionate use KW - crop production KW - compounding pharmacy KW - antimicrobial resistance (AMR) KW - best practices KW - bacteriophage efficacy KW - phage sensitivity KW - antibiotic-resistance KW - antibiotic KW - lysins KW - PTMP KW - Escherichia coli KW - typhoid fever KW - patent landscape KW - phage preparation KW - innate immunity KW - anti-phage antibodies KW - immunology KW - Staphylococcus aureus KW - global health KW - clinical trial KW - adsorption KW - Brussels KW - phage-resistance KW - Galleria mellonella KW - science communication KW - history of science KW - virus-host interactions KW - foodborne illness KW - prophage KW - resistance management KW - biofilms KW - IND KW - immunomodulation KW - frequency of resistance KW - capsule KW - gastrointestinal tract KW - phage-host interactions KW - disinfection KW - production KW - bacteriophage therapy KW - bacteriophage KW - Staphylococcus KW - magistral preparation KW - extended-spectrum beta lactamases (ESBL) KW - Viral proteins KW - antibiotic resistance KW - genomics KW - phage biocontrol KW - therapy KW - target selection KW - viral genomes KW - evolution KW - pharmaceutical paradigm shift KW - personalized medicine KW - pharmaceutical legislation KW - food safety KW - regulation KW - virulence KW - developing countries KW - infectious disease KW - regulatory framework KW - sustainable agriculture KW - Klebsiella pneumoniae N1 - Open Access N2 - Alternative treatment modes for antibiotic-resistant bacterial pathogens have become a public health priority. Bacteriophages are bacterial viruses that infect and lyse bacterial cells. Since bacteriophages are frequently bacterial host species-specific and can often also infect antibiotic-resistant bacterial cells, they could represent ideal antimicrobials for fighting the antibiotic resistance crisis. The medical use of bacteriophages has become known as phage therapy. It is widely used in Russia, where phage cocktails are sold in pharmacies as an over-the-counter drug. However, no phage product has been registered for medical purposes outside of the former Soviet Union. The current Special Issue of Viruses contains a collection of papers from opinion leaders in the field who explore hurdles to the introduction of phage therapy in western countries. The articles cover diverse topics ranging from patent to regulatory issues, the targeting of suitable bacterial infections, and the selection and characterization of safe and efficient phage cocktails. Phage resistance is discussed, and gaps in our knowledge of phage-bacterium interactions in the mammalian body are revealed, while other articles explore the use of phages in food production and processing UR - https://mdpi.com/books/pdfview/book/1504 UR - https://directory.doabooks.org/handle/20.500.12854/49693 ER -